Epigenetic markers in rectal cancer.


Journal Article (Review)

DNA methylation changes in rectal cancer may serve as a new screening marker and a tool for monitoring recurrence. Importantly, these changes may also function as a predictive marker to allow appropriate exclusion of (neo)adjuvant therapies in patients at low risk for disease recurrence, sparing them from potential treatment-related morbidities.

Full Text

Duke Authors

Cited Authors

  • Xu, L; Czito, BG; Willett, CG

Published Date

  • May 15, 2010

Published In

Volume / Issue

  • 16 / 10

Start / End Page

  • 2699 - 2701

PubMed ID

  • 20460492

Pubmed Central ID

  • 20460492

International Standard Serial Number (ISSN)

  • 1078-0432

Digital Object Identifier (DOI)

  • 10.1158/1078-0432.CCR-10-0559


  • eng

Conference Location

  • United States